Detalhe da pesquisa
1.
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Oncologist
; 26(8): e1327-e1338, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028126
2.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909203
3.
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 159(1): 150-156, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723675
4.
Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Br J Clin Pharmacol
; 83(3): 554-561, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628584
5.
Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib.
J Transl Med
; 10: 165, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22897944
6.
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.
Clin Cancer Res
; 27(21): 5818-5827, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380637
7.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
J Clin Oncol
; 38(27): 3138-3149, 2020 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678716
8.
Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects.
Cancer Chemother Pharmacol
; 84(5): 1125-1132, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512028
9.
LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.
J Pharm Biomed Anal
; 134: 130-136, 2017 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27907855